http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0135986-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d189b10028d1697dc0392efe2902921
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4229c3b23c9809bf6b6e55d46bfd9474
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41424fefe02821e242f46441416f4e71
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-044
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-202
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
filingDate 2000-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b5da74e09abcb2455fed92f05eb7e1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9e74f4e9d6c92a7e7f8d7354d1e3dcc
publicationDate 2001-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0135986-A3
titleOfInvention Methods and compositions for modulating er-stress-induced cholesterol accumulation
abstract The present invention provides methods for preventing the accumulation of cholesterol/triglycerides within mammalian cells. The present methods are based upon the surprising discovery that ER stress in a cell leads to cholesterol/triglyceride accumulation within the cell, which cholesterol/triglyceride accumulation is often a causative factor in the development of any of a number of conditions or diseases, such as atherosclerosis. The ER stress can be the result of any of a variety of causes, including homocysteine, viral infection, and hypoxia. Accordingly, counteracting the progression or the severity of ER stress can be used to inhibit the accumulation of cholesterol/triglycerides in said cell, thereby preventing or lessening the severity of any of a number of cholesterol-related diseases or conditions, e.g., atherosclerosis. In addition, the presence of ER stress in a cell can be used to diagnose a cholesterol associated disease, or to predict the propensity of a mammal to develop a disease.
priorityDate 1999-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9636643-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5274088-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02124100-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0020577-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0029429-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953

Total number of triples: 28.